Bayer Cipro Anthrax Prophylaxis Safety Data Will Be Gathered By CDC

Bayer will provide tracking data on the use of Cipro (ciprofloxacin) for post-exposure prophylaxis to FDA in accordance with its post-marketing commitments for the product

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet